Biomet Inc. has acquired Cartilix Inc., a Foster City, Calif.-based developer of biomaterials to repair damaged tissues in articular joints. No financial terms were disclosed. Cartilix had raised $6.5 million in Series A funding led by De Novo Ventures.
